Cc1ccc2c(c1)c(N1CCCC1=O)c(C(=O)Nc1ccc(F)cc1F)n2C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?